IDEA-FAST
Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases
Site Search
Site Search
Displaying results 291 - 300 of 893
Sign up for the IMI2 – Call 20 webinars
IMI2 – Call 20 will be launched in January 2020 and features topics on cancer, tuberculosis, psoriasis, drugs based on proteins, and vaccines. Registration is now open for the IMI2 - Call 20 webinars, which will be held from 22 to 31 January 2020 inclusive. Registration is free ...
IMI2 - Call 20 webinars
IMI held webinars on IMI2 – Call 20 from Wednesday 22 January to Tuesday 31 January. All webinars on the Call topics featured a presentation by the EFPIA topic coordinator and time for questions and answers. The webinars represent an excellent opportunity to learn more about the ...
Cache of research materials on understudied proteins now available to scientific community
The RESOLUTE project have made the DNA reagents for 446 solute carriers freely available in the hope that the proteins might be used as targets in drug development
Alzheimer’s project EPAD releases first wave of data to research community
The data comes from EPAD’s study into the earliest stages of Alzheimer’s dementia – before symptoms appear.
Alzheimer's researchers use AI to get access to brains
The Aetionomy project used digital technology to study brains without needing samples from living people, allowing them to simulate processes associated with Alzheimer's.
imSAVAR
Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
COMBINE
Collaboration for prevention and treatment of MDR bacterial infections
EU-PEARL
EU patient-centric clinical trial platform